RESUMO
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the fourth of a series of five and deals mainly with neurological paraneoplastic syndromes involving the peripheral nervous system and the neuromuscular junction and muscles.
Assuntos
Doenças Autoimunes/complicações , Doenças Autoimunes/imunologia , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/epidemiologia , Síndromes Paraneoplásicas/complicações , Síndromes Paraneoplásicas/imunologia , Autoanticorpos/imunologia , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/terapia , Autoimunidade , Humanos , Músculos/imunologia , Músculos/patologia , Junção Neuromuscular/imunologia , Junção Neuromuscular/patologia , Síndromes Paraneoplásicas/diagnóstico , Síndromes Paraneoplásicas/terapia , Síndromes Paraneoplásicas do Sistema Nervoso/complicações , Síndromes Paraneoplásicas do Sistema Nervoso/imunologia , Síndromes Paraneoplásicas do Sistema Nervoso/patologia , Sistema Nervoso Periférico/imunologia , Sistema Nervoso Periférico/patologiaRESUMO
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the last of a series of five and deals mainly with onconeural antibodies involved in neurological paraneoplastic syndromes and provides the final discussion.
